LabConnect, LLC, a provider of central laboratory and support services for biopharmaceutical, medical device and contract research organizations, has completed phase one of an 11,000+ square foot facility expansion in Johnson City, TN. The new space will increase the capacity for peripheral blood mononuclear cell (PBMC) processing. As a response to its 30 percent growth since 2017, LabConnect said its facility expansion is essential to serving increasingly complex studies and the related dema...